Bull
$4.12
Scenario price
$0.828
+0.007 (+0.83%)At close
Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. The smart eyewear products enable the wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform many common smartphone tasks hands-free. It has created a smart upgrade for all four of the major types of eyewear: prescription eyeglasses, ready-to-wear sunglasses, safety glasses, and sports glasses. Its brands include Lucyd, Nautica, Eddie Bauer and Reebok brands. Its first commercial product, Lucyd Lyte, enables the wearer to remain connected to their digital lives. Its product offering consists of approximately 26 different models, which offer a similar amount of style variety as many traditional eyewear collections. All styles are each available with 100+ different lens types. It has over 115 patents and applications.
Innovative Eyewear Inc (LUCY) is currently not a strong buy. The stock is trading at $0.83, which is significantly lower than its 52-week high of $2.02, indicating a substantial decline of 58.92%. Additionally, the RSI is at 43.22, suggesting that the stock is nearing oversold territory but not yet at a strong buy signal. The forward P/E ratio is currently at 0, indicating uncertainty in future earnings, and the company has reported consistent losses, with a net income of -$2,309,368 in Q1 2026. The main risk is the ongoing negative net margins, which stand at -298.54% for Q1 2026, reflecting serious profitability challenges. Therefore, while there are signs of revenue growth, the overall financial health and profitability concerns suggest that holding is the best course of action for now.
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Innovative Eyewear Launches Lucyd Aero Smart Glasses Collection

Innovative Eyewear Reports Significant Growth in Q3 2026

Innovative Eyewear Launches Lucyd Armor Smart Glasses in Major Retail Rollout

Innovative Eyewear Launches Lucyd Armor Smart Glasses in Major Retail Rollout

Innovative Eyewear Reports 74% Revenue Growth in Q2
Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. The smart eyewear products enable the wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform many common smartphone tasks hands-free. It has created a smart upgrade for all four of the major types of eyewear: prescription eyeglasses, ready-to-wear sunglasses, safety glasses, and sports glasses. Its brands include Lucyd, Nautica, Eddie Bauer and Reebok brands. Its first commercial product, Lucyd Lyte, enables the wearer to remain connected to their digital lives. Its product offering consists of approximately 26 different models, which offer a similar amount of style variety as many traditional eyewear collections. All styles are each available with 100+ different lens types. It has over 115 patents and applications. It operates in the Healthcare sector (OPHTHALMIC GOODS industry).
Innovative Eyewear Inc (LUCY) is currently not a strong buy. The stock is trading at $0.83, which is significantly lower than its 52-week high of $2.02, indicating a substantial decline of 58.92%. Additionally, the RSI is at 43.22, suggesting that the stock is nearing oversold territory but not yet at a strong buy signal. The forward P/E ratio is currently at 0, indicating uncertainty in future earnings, and the company has reported consistent losses, with a net income of -$2,309,368 in Q1 2026. The main risk is the ongoing negative net margins, which stand at -298.54% for Q1 2026, reflecting serious profitability challenges. Therefore, while there are signs of revenue growth, the overall financial health and profitability concerns suggest that holding is the best course of action for now.
No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.